These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38688943)

  • 1. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
    Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
    Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
    Evans BA; Bernstein DA
    mSphere; 2021 May; 6(3):. PubMed ID: 34011687
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAMless SpRY exhibits a preference for the seed region for efficient targeting.
    Yang C; Zhou Z; Sun X; Ju H; Yue X; Rao S; Xue C
    Cell Rep; 2024 May; 43(5):114225. PubMed ID: 38733582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the Genome-Editing Toolbox with
    Nakamura A; Yamamoto H; Yano T; Hasegawa R; Makino Y; Mitsuda N; Terakawa T; Ito S; Sugano SS
    CRISPR J; 2024 Aug; 7(4):197-209. PubMed ID: 39111827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
    Zhang D; Zhang B
    Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
    Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
    Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can SpRY recognize any PAM in human cells?
    Ye J; Xi H; Chen Y; Chen Q; Lu X; Lv J; Chen Y; Gu F; Zhao J
    J Zhejiang Univ Sci B; 2022 May; 23(5):382-391. PubMed ID: 35557039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
    Briner AE; Henriksen ED; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
    Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
    Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
    Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
    Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
    Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
    Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.
    Asano Y; Yamashita K; Hasegawa A; Ogasawara T; Iriki H; Muramoto T
    Sci Rep; 2021 May; 11(1):11163. PubMed ID: 34045481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.
    Vicencio J; Sánchez-Bolaños C; Moreno-Sánchez I; Brena D; Vejnar CE; Kukhtar D; Ruiz-López M; Cots-Ponjoan M; Rubio A; Melero NR; Crespo-Cuadrado J; Carolis C; Pérez-Pulido AJ; Giráldez AJ; Kleinstiver BP; Cerón J; Moreno-Mateos MA
    Nat Commun; 2022 May; 13(1):2601. PubMed ID: 35552388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
    Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
    Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.